International Patent: CHIMERIC ANTIGEN RECEPTOR-MODIFIED CELL DRUG, PREPARATION METHOD THEREFOR, AND USE THEREOF

GENEVA, July 31 -- GUANGZHOU ANJIE BIOMEDICAL TECHNOLOGY CO; LTD filed a patent application (CN2025/105893) for “CHIMERIC ANTIGEN RECEPTOR-MODIFIED CELL DRUG, PREPARATION METHOD THEREFOR, AND USE THEREOF”. With publication no. WO/2026/157129, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 40/11

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....